跳至主要内容
临床试验/NCT07106996
NCT07106996招募中1 期

Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycystic Ovary Syndrome

Sichuan Provincial People's Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年7月28日最近更新:
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
90
试验地点
1
主要终点
inflammatory marker IL1β [pg/ml]

研究概览

简要总结

The aim of this study is to elucidate the effects of red yeast rice on the improvement of symptoms in patients with polycystic ovary syndrome(PCOS), and to analyze the dose-response relationship between intestinal microbiota and its metabolite, hydroxyindole, and clinical indicators of PCOS.

The main questions it aims to answer are:

How effective is red yeast rice in treating PCOS? Does the indole metabolic pathway of gut microbiota play a crucial role in the improvement of PCOS symptoms by red yeast rice? Participants will take 6 grams of red yeast rice daily for 6 months, and records will be kept of their PCOS clinical symptoms and indicators before the intervention, at the 3rd month post-intervention, and at the 6th month post-intervention. Additionally, biological samples from feces and serum will be collected at these time points.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Accept the red yeast rice intervention group

Experimental

Red yeast rice (RYR), a fermented product that has both medicinal and edible properties, is one of the traditional Chinese medicines used in the treatment of metabolic diseases. The main components of red yeast rice include monacolins, monacolin K, red yeast rice pigments, ergosterol, stigmasterol, β-sitosterol, daucosterol.

干预措施: red yeast rice,RYR (Drug)

结局指标

主要结局

inflammatory marker IL1β [pg/ml]

时间窗: Baseline, the 3rd month and the 6th month after the intervention

testosterone (nmol/l)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

Follicle - Stimulating Hormone (mIU/mL)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

inflammatory marker IL18 [pg/ml]

时间窗: Baseline, the 3rd month and the 6th month after the intervention

Luteinizing Hormone (mIU/mL)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

Estradiol (pmol/l)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

Progesterone (ng/mL)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

Prolactin (ng/mL)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

follicles number

时间窗: Baseline, the 3rd month and the 6th month after the intervention

The number of follicles in each ovary of each participant will be determined by ultrasonography.

ovarian volume(Length x Width x Thickness/2,ml)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

The size of each ovary in each participant will be determined by ultrasonography.

Follicle diameter(mm)

时间窗: Baseline, the 3rd month and the 6th month after the intervention

The diameter of the follicles will be determined by ultrasonography.

Hydroxyindole concentration

时间窗: Baseline, the 3rd month and the 6th month after the intervention

次要结局

  • Body-mass-index (BMI)(Baseline, the 3rd month and the 6th month after the intervention)
  • waist-to-hip ratio(Baseline, the 3rd month and the 6th month after the intervention)

研究者

发起方
Sichuan Provincial People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhengwei Wan

professor

Sichuan Provincial People's Hospital

研究点 (1)

Loading locations...

相似试验